Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Nature’s Fury Unleashed

In Washington, D.C. yesterday, we got walloped first with thundersleet, then thundersnow, that made a mess of traffic and downed power lines. Our power lines were among the casualties, but fortunately we got our juice restored this morning and we’re back in business. Thank you for your patience.

* * *

Collaboration Tracks Solar Streams Disrupting Communications

A university-government partnership is making operational a prediction model designed for weather forecasting, and put into use to track solar activity that disrupts communications. The Center for Integrated Space Weather Modeling (CISM) at Boston University and the National Oceanic and Atmospheric Administration (NOAA) Space Weather Prediction Center reported the news of the collaboration today at . . . → Read More: Collaboration Tracks Solar Streams Disrupting Communications

Pathology Lab, Institute Partner on Cancer Drug Services

Flagship Biosciences, a pathology lab in Flagstaff, Arizona and TGen Drug Development (TD2), in Scottsdale, Arizona, have teamed up to provide drug discovery and development services to cancer researchers. Flagship Biosciences is a pharmaceutical services company that offers digital pathology to test diseased tissue samples for biotech, pharmaceutical, and medical device customers. TD2 is a . . . → Read More: Pathology Lab, Institute Partner on Cancer Drug Services

Paper Strip Technique Devised for Complex Diagnostics

Demonstration of a technique that uses inexpensive paper as a medium for rapid medical diagnostics and chemical analysis. Blood was sprayed on the test strip that turns a fluorescent blue, showing the presence of hemoglobin. (Birck Nanotechnology Center, Purdue University)

Researchers at Purdue University in West Lafayette, Indiana have developed a technique using . . . → Read More: Paper Strip Technique Devised for Complex Diagnostics

New Process Discovered for Fighting Contact Lens Bacteria

(Etan J. Tal/Wikimedia Commons)

Researchers at National Jewish Health in Denver, Colorado and the University of Texas Southwestern Medical Center in Dallas, Texas have discovered a new method to fight bacterial infections from contact lenses. The results were published online January 18 in the journal Investigative Ophthalmology and Visual Science (paid subscription required).

. . . → Read More: New Process Discovered for Fighting Contact Lens Bacteria

Researchers Improve Efficiency of LED Lighting

(Alexofdodd/Wikipedia)

Researchers from North Carolina State University in Raleigh have developed a new technique that reduces defects in the gallium nitride (GaN) films used to create light-emitting diodes or LEDs, making this energy-efficient form of lighting even more efficient. The team of engineers and and materials scientists published their findings online in the . . . → Read More: Researchers Improve Efficiency of LED Lighting

Grant Awarded to Company for Kennedy’s Disease Research

(National Institute on Aging, NIH)

AndroScience Corp., a drug discovery and development company in San Diego, California, said it received a $3.8 million translational research grant to help develop a treatment for spinal and bulbar muscular atrophy, also called Kennedy’s Disease. The National Institute of Neurological Disorders and Stroke (NINDS) of the National . . . → Read More: Grant Awarded to Company for Kennedy’s Disease Research

Orphan Drug Status Granted for Melanoma Vaccine

(NOAA)

BioSante Pharmaceuticals Inc. said today it received from the U.S. Food and Drug Administration orphan drug designation for its melanoma cancer vaccine to treat stage IIb to IV melanoma. BioSante Pharmaceuticals is a specialty pharmaceutical company in Lincolnshire, Illinois.

Orphan drug designation, as granted by the Orphan Drug Act, is for a . . . → Read More: Orphan Drug Status Granted for Melanoma Vaccine

Heart Disease Treatment Cost Expected to Triple by 2030

(WomensHealth.gov)

An economic forecast by an American Heart Association (AHA) panel indicates that the cost to treat heart disease in the United States is expected to triple to $818 billion by 2030 from $273 billion in 2010. The findings are contained in a policy statement published in the online issue of Circulation: Journal . . . → Read More: Heart Disease Treatment Cost Expected to Triple by 2030

Engineers Develop Wireless Spectrum-Sensing Algorithms

Researchers at Virginia Tech in Blacksburg have developed a set of mathematical rules to help build more reliable and efficient spectrum-sensing techniques needed to meet the expanding demand for wireless technologies. This first phase of a more than two-year study is funded by wireless technology developer InterDigital of King of Prussia, Pennsylvania.

Spectrum-sensing technologies are . . . → Read More: Engineers Develop Wireless Spectrum-Sensing Algorithms